References:
1. Fomin A.B., Pastorino A.C., Kim C.A., Pereira C.A., Carneiro-Sampaio
M., and Abe-Jacob C.M., DiGeorge Syndrome: a not so rare disease.Clinics (Sao Paulo), 2010. 65 (9): p.
865-9.10.1590/s1807-59322010000900009
2. Dali-Youcef N. and Andrès E., An update on cobalamin deficiency
in adults. Qjm, 2009. 102 (1): p. 17-28.10.1093/qjmed/hcn138
3. Acharya U., Gau J.T., Horvath W., Ventura P., Hsueh C.T., and Carlsen
W., Hemolysis and hyperhomocysteinemia caused by cobalamin
deficiency: three case reports and review of the literature. J Hematol
Oncol, 2008. 1 : p. 26.10.1186/1756-8722-1-26
4. Koury M.J. and Ponka P., New insights into erythropoiesis: the
roles of folate, vitamin B12, and iron. Annu Rev Nutr, 2004.24 : p. 105-31.10.1146/annurev.nutr.24.012003.132306
5. Ventura P., Panini R., Tremosini S., and Salvioli G., A role
for homocysteine increase in haemolysis of megaloblastic anaemias due to
vitamin B(12) and folate deficiency: results from an in vitro
experience. Biochim Biophys Acta, 2004. 1739 (1): p.
33-42.10.1016/j.bbadis.2004.08.005
6. Olinescu R., Kummerow F.A., Handler B., and Fleischer L., The
hemolytic activity of homocysteine is increased by the activated
polymorphonuclear leukocytes. Biochem Biophys Res Commun, 1996.226 (3): p. 912-6.10.1006/bbrc.1996.1449
7. Pinchas-Hamiel O., Mandel M., Engelberg S., and Passwell J.H.,Immune hemolytic anemia, thrombocytopenia and liver disease in a
patient with DiGeorge syndrome. Isr J Med Sci, 1994. 30 (7): p.
530-2
8. Kratz C.P., Niehues T., Lyding S., Heusch A., Janssen G., and Göbel
U., Evans syndrome in a patient with chromosome 22q11.2 deletion
syndrome: a case report. Pediatr Hematol Oncol, 2003. 20 (2):
p. 167-72.10.1080/0880010390158685
9. DePiero A.D., Lourie E.M., Berman B.W., Robin N.H., Zinn A.B., and
Hostoffer R.W., Recurrent immune cytopenias in two patients with
DiGeorge/velocardiofacial syndrome. J Pediatr, 1997. 131 (3):
p. 484-6.10.1016/s0022-3476(97)80085-6
10. Davies J.K., Telfer P., Cavenagh J.D., Foot N., and Neat M.,Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab
Haematol, 2003. 25 (3): p.
195-7.10.1046/j.1365-2257.2003.00508.x
11. Bruno B., Barbier C., Lambilliotte A., Rey C., and Turck D.,Auto-immune pancytopenia in a child with DiGeorge syndrome. Eur J
Pediatr, 2002. 161 (7): p. 390-2.10.1007/s00431-002-0976-y
12. Soldatou A., Anastassiou T., Vougiouka O., Goussetis E., and Kossiva
L., Transient effect of anti-CD20 therapy in a child with 22q11.2
deletion syndrome and severe steroid refractory cytopenias: a case
report. J Pediatr Hematol Oncol, 2013. 35 (4): p.
311-4.10.1097/MPH.0b013e31828be602
13. Sakamoto O., Imaizumi M., Suzuki A., Sato A., Tanaka T., Ogawa E.,
et al., Refractory autoimmune hemolytic anemia in a patient with
chromosome 22q11.2 deletion syndrome. Pediatr Int, 2004.46 (5): p. 612-4.10.1111/j.1442-200x.2004.01940.x
14. Damlaj M. and Séguin C., Refractory autoimmune hemolytic
anemia in a patient with DiGeorge syndrome treated successfully with
plasma exchange: a case report and review of the literature. Int J
Hematol, 2014. 100 (5): p. 494-7.10.1007/s12185-014-1648-1
15. Montin D., Marolda A., Licciardi F., Robasto F., Di Cesare S.,
Ricotti E., et al., Immunophenotype Anomalies Predict the
Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome. The
Journal of Allergy and Clinical Immunology: In Practice, 2019.7 (7): p.
2369-2376.https://doi.org/10.1016/j.jaip.2019.03.014